Transcriptional Upregulation of C-Myc by AXL Confers Epirubicin Resistance in Esophageal Adenocarcinoma

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12395
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

B-Myc Inhibits Neoplastic Transformation and Transcriptional Activation by C-Myc.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1993English

Regulation of OGT by URI in Response to Glucose Confers C-Myc-Dependent Survival Mechanisms

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL

Cancer Research
Cancer ResearchOncology
2007English

Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to Streptococcus Pseudopneumoniae

Frontiers in Microbiology
Microbiology
2017English

VRK1 Promotes Cisplatin Resistance by Up-Regulating C-Myc via C-Jun Activation and Serves as a Therapeutic Target in Esophageal Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

Recent Advances in Searching C-Myc Transcriptional Cofactors During Tumorigenesis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Upregulation of Id1 by Epstein-Barr Virus-Encoded LMP1 Confers Resistance to TGFβ-mediated Growth Inhibition

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Targeting Cyclin-Dependent Kinase 9 by a Novel Inhibitor Enhances Radiosensitization and Identifies Axl as a Novel Downstream Target in Esophageal Adenocarcinoma

Oncotarget
Oncology
2019English

C-Myc Modulates microRNA Processing via the Transcriptional Regulation of Drosha

Scientific Reports
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy